Results 141 to 150 of about 872,427 (309)

DNA haemagglutination test in the diagnosis of systemic lupus erythematosus. [PDF]

, 1965
E. J. Jokinen, Heikki Julkunen
openalex   +1 more source

Maternal gut microbiota‐derived daidzein prevents osteoporosis in female offspring following prenatal prednisone exposure

iMeta, EarlyView.
Prenatal prednisone therapy (PPT)/prenatal prednisone exposure (PPE) induces long bone dysplasia, reduced peak bone mass (PBM), and increased osteoporosis susceptibility in female offspring. Maternal gut microbiota metabolite daidzein (DAI) mediates PPE‐induced osteoporosis susceptibility in female adult offspring.
Chi Ma, Hangyuan He, Kunpeng Wang, Juanjuan Guo, Liang Liu, Yuting Chen, Bin Li, Hao Xiao, Xufeng Li, Xiaoqian Lu, Tingting Wang, Yinxian Wen, Hui Wang, Liaobin Chen   +13 more
wiley   +1 more source

Pericardial Effusion, a Manifestation of Systemic Lupus Erythematosus [PDF]

, 1960
Stanley S. Bergen
openalex   +1 more source

Mitochondrial dysfunction: Related diseases, influencing factors, and detection

Interdisciplinary Medicine, EarlyView.
Mitochondrial dysfunction is implicated in the pathogenesis of numerous diseases, including neurological disorders, cancers, and cardiovascular conditions, through mechanisms such as mitochondrial DNA mutations, dysregulation of mitochondrial network dynamics, and impaired mitophagy.
Zhaojin Li, Shiyu Li, Wanying Chen, Ziyu Zhang, Chun Pan, Peng Lei, Cheng Cheng, Junyou Zhu, Hanxiao Sun, Zhenning Dai   +9 more
wiley   +1 more source

Varying Specificity of Systemic Lupus Erythematosus Sera for Histone Fractions and a Periodatesensitive Antigen Associated with Histone [PDF]

, 1969
B. David Stollar
openalex   +1 more source

Indication‐Specific Dosing and Dose‐Evaluation Strategies in New Indications for Non‐Oncology Monoclonal Antibodies

The Journal of Clinical Pharmacology, EarlyView.
Abstract Compared to traditional small molecule drugs, monoclonal antibodies (mAbs) often display more complex pharmacokinetic (PK) and pharmacodynamic (PD) properties that may be impacted by disease‐specific factors. For mAbs in non‐oncology indications, where the same drug might be used for conditions involving different organ systems and/or having ...
Sherouk M. Tawfik, Fei Tang
wiley   +1 more source

Production of Lupus Erythematosus (L.E.) Cells in the Dog by the Transfusion of Systemic Lupus Erythematosus Plasma [PDF]

, 1960
G. Bencze, M. Ludanyi
openalex   +1 more source

Recurrent Osler's Nodes in Systemic Lupus Erythematosus [PDF]

, 1969
Basil M. RuDusky
openalex   +1 more source

Systemic Lupus Erythematosus [PDF]

Postgraduate Medical Journal, 1958
Misra Dp, McCARTHY Tf
openaire   +3 more sources

Evaluation of damage index and its association with risk factors in patients with systemic lupus erythematosus

Journal of Research in Medical Sciences, 2011
Background: This study aimed to determine the value of damage index in patients with systemic lupus erythematosus (SLE) and the association between damage index and disease severity, flare up numbers, disease duration, and antiphospholipid antibodies ...
Zahra Sayed Bonakdar, Negin Mohtasham, Mansoor Karimifar   +2 more
doaj